ArticleTanaffos2018
Effect of Chamomile Hydroalcoholic Extract on Bleomycin-Induced Pulmonary Fibrosis in Rat.
Article in Tanaffos, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
- A Comprehensive Review of Edible Flowers with a Focus on Microbiological, Nutritional, and Potential Health Aspects.Foods (Basel, Switzerland) · 2025Review
- A Comprehensive Study of Therapeutic Applications of Chamomile.Pharmaceuticals (Basel, Switzerland) · 2022Review
- Nutraceuticals as potential therapeutics for vesicant-induced pulmonary fibrosis.Annals of the New York Academy of Sciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of the present study was to investigate the effect of the Chamomile hydroalcoholic extract on bleomycin-induced pulmonary fibrosis in rat. MATERIALS AND
methodsRats (N.Mari, 180-220 g) of either sex were given a single intratracheal instillation of bleomycin (7.5 IU/Kg) or the vehicle (saline). Treatment groups were given the same dose of bleomycin and then received different doses of oral chamomile hydroalcoholic extract (400, 600, 800, 1000, and 1500 mg/kg/day) for two weeks.
resultsHistological and pharmacological experiments of bleomycin-treated animals showed that bleomycin could cause marked pulmonary fibrosis within two weeks. In addition, administration of Chamomile hydroalcoholic extract reduced such damages in lung tissue in a dose-dependent manner. Best results were obtained with 1500 /kg/day of Chamomile hydroalcoholic extract.
conclusionFrom the results of current study, it can be concluded that Chamomile hydroalcoholic extract may be able to diminish the toxic effects of bleomycin on the lung tissues. Such effect of Chamomile can be attributed to the ingredients of this plant with anti-inflammatory and anti-oxidant properties.
Indexed as
Identifiers
31143217PMC6534797W2989003100What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.